Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Schizophr Res ; 166(1-3): 201-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26004686

ABSTRACT

OBJECTIVES: We tested the hypothesis that metabolic disturbances in people with schizophrenia exist as a part of the schizophrenic syndrome, even when the antipsychotic drug effect is eliminated. We aimed to determine the prevalence of metabolic syndrome among patients with schizophrenia who were antipsychotic drug-naive or drug-free and their siblings for comparison with healthy controls. METHODS: One-hundred-two patients with schizophrenia (drug-naïve or drug-free), 64 siblings and 70 age-matched healthy subjects were recruited for this case-control study. Metabolic syndrome was assessed based on Adult Treatment Panel (ATP) III, adapted ATP III and International Diabetes Federation criteria. Student's t-tests, chi-squared tests, Kruskal-Wallis tests and Bonferroni corrections were used as appropriate. RESULTS: The diagnoses of metabolic syndrome and metabolic disturbances as a subsyndromal state were found to be significantly more frequent in patients and their siblings than in the controls. Low levels of high-density lipoprotein cholesterol and disturbances in blood pressure put the patient group at risk for metabolic syndrome even before they were exposed to antipsychotic drugs. CONCLUSIONS: Although antipsychotic drugs have consistently been related to disturbances of glucose and lipid metabolism in patients with schizophrenia, this study showed that patients with schizophrenia and their siblings are already at a high risk for metabolic syndrome independent of any antipsychotic effects. These individuals should be monitored regularly following a diagnosis of schizophrenia.


Subject(s)
Metabolic Diseases/epidemiology , Schizophrenia/epidemiology , Adult , Antipsychotic Agents/therapeutic use , Case-Control Studies , Comorbidity , Family , Female , Humans , Male , Metabolic Diseases/diagnosis , Metabolic Diseases/pathology , Metabolic Diseases/physiopathology , Prevalence , Schizophrenia/drug therapy , Schizophrenia/pathology , Schizophrenia/physiopathology , Turkey/epidemiology
2.
FEMS Microbiol Ecol ; 84(1): 133-42, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23167955

ABSTRACT

Surficial riverbed sediments are often characterized by sharp redox gradients between the aerobic benthic sediment and underlying anoxic sediment, potentially representing an ideal niche for aerobic and anaerobic vinyl chloride (VC) degraders. To test this, the fate of VC in aerobic and anaerobic microcosms containing surficial sediment of a riverbed hyporheic zone receiving VC-contaminated groundwater was explored. Quantitative PCR showed that Dehalococcoides 16S rRNA gene and VC reductive dehalogenase-encoding genes (vcrA, bvcA) were highly enriched in anaerobic microcosms, with stoichiometric conversion of VC to ethene. In aerobic microcosms, etnC and etnE involved in aerobic ethene/VC oxidation were enriched with concomitant low or no accumulation of ethene. However, Dehalococcoides 16S rRNA gene, vcrA and bvcA copy numbers were also enriched in oxygen-exposed microcosms containing sediment with high organic carbon and small grain size, whereas they were reduced in oxygen-exposed sediment with low organic carbon and larger grain size in line with extensive oxygen penetration into the sediment. These results suggest the coexistence and coactivity of anaerobic and aerobic VC degraders in the same small volume of surficial sediment and that oxygen distribution, as determined by sediment grain size and organic matter content, affects the local VC-degrading bacterial community and VC biodegradation pathway.


Subject(s)
Geologic Sediments/microbiology , Oxygen/analysis , Vinyl Chloride/metabolism , Water Pollutants, Chemical/metabolism , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/metabolism , Biodegradation, Environmental , Chloroflexi/genetics , Chloroflexi/isolation & purification , Chloroflexi/metabolism , Ethylenes/metabolism , Genes, Bacterial , Geologic Sediments/chemistry , Oxidation-Reduction , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics , Rivers
3.
Drug Chem Toxicol ; 28(3): 289-301, 2005.
Article in English | MEDLINE | ID: mdl-16051555

ABSTRACT

In this study, four textile dyes, namely Astrazon Yellow, Red, Blue, and Black, were tested for their genotoxic effects in the wing cells of Drosophila melanogaster. Two crosses were used, the standard cross (ST) and the improved high-bioactivation cross (HB), the latter being characterized by increased sensitivity to the genotoxic effects of promutagens and procarcinogens. Three-day-old larvae were exposed to different concentrations of dyes. Commonly known mutagens were applied as positive controls. All concentrations of textile dyes, ethyl methanesulfonate (EMS), and urethane caused a decrease in survival proportional to concentration used. EMS and urethane caused an increase in the number of all types of spots in both standard and high-bioactivation crosses. Compared to ST crosses, the number of induced spots in the HB cross treated with urethane was considerably high. Treatment of the standard and the high-bioactivation crosses with textile dyes gave positive results, apparent from increase in the frequency of the small single spots. Yellow and red dyes also increased the number of large single spots in both crosses, whereas the twin spots were positive only at the highest dose of yellow dye. All these results indicate that D. melanogaster wing spot test can be recommended as a suitable in vivo test for the determination of genotoxicity of textile dyes.


Subject(s)
Coloring Agents/toxicity , Mutagens/toxicity , Mutation/drug effects , Recombination, Genetic/drug effects , Textiles , Wings, Animal/physiology , Animals , Cytochrome P-450 Enzyme System/metabolism , Drosophila melanogaster , Larva , Mutagenicity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...